Bin-Chi Liao

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non–Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis

Bin-Chi Liao, Jih‐Hsiang Lee, Chia‐Chi Lin et al. · Journal of Thoracic Oncology · 2015 · 190 citations · Full text

Medicine, Receptor Tyrosine Kinase, Leptomeningeal Carcinomatosis +7

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

Ching‐Yao Yang, Wei‐Yu Liao, Chao‐Chi Ho et al. · European Journal of Cancer · 2019 · 89 citations

Medicine, Immunology, Pathology +11

Exon 16–Skipping HER2 as a Novel Mechanism of Osimertinib Resistance in EGFR L858R/T790M–Positive Non–Small Cell Lung Cancer

Chia‐Chi Hsu, Bin-Chi Liao, Wei‐Yu Liao et al. · Journal of Thoracic Oncology · 2019 · 82 citations · Full text

Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis

Hsiang‐Fong Kao, Bin-Chi Liao, Yenlin Huang et al. · Clinical Cancer Research · 2022 · 63 citations · Full text

Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan

Shu‐Yung Lin, Ching‐Yao Yang, Bin-Chi Liao et al. · Journal of Cancer · 2018 · 55 citations · Full text